Small-cap Sector Updates: Biotech Research, Gold Explorers, Consumer Brands
The S&P/ASX Small Ordinaries Index (XSO) showed resilience with a slight decline in the latest session but gained over 1.3% in five days. Percheron Therapeutics highlighted new research at ASCO and Nova Minerals made progress on its U.S. redomiciliation.
Topics: biotech consumer_brands corporate_restructuring gold_exploration